Adults aged 18 to 65, inclusive, with a clinical diagnosis of moderate-to-severe alopecia areata (AA), defined as the presence of 50% or more and 95% or less total scalp hair loss, may qualify for a research trial. Qualified participants must have a current episode of hair loss lasting more than 3 months, but less than 7 years. The total duration since diagnosis of AA could be over 7 years.
Participants will receive investigational medication (active study drug) via injection. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Total study duration will last about 52 weeks and involve about 14 visits to the study centre.
Call the study centre near you, or register now.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
By registering you are consenting to the terms and conditions of our privacy policy.
Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more
© 2014 All Rights Reserved Probity Medical Research Inc.